| Financial Year |
March 31 2023 |
| Monetary Funds |
1,292,887,588.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
239,867,124.83 |
| Accounts Receivable |
4,258,258,730.03 |
| Advances to Suppliers |
1,098,265,568.84 |
| Other Receivables |
168,865,953.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,080,209,370.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
9,638,839.44 |
| Other Current Assets |
42,771,152.75 |
| Total Current Assets |
9,300,332,395.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
125,943,946.85 |
| Long-term Equity Investment |
875,702,800.34 |
| Investment Properties |
59,012,106.49 |
| Fixed Assetes |
840,051,010.51 |
| Under-construction Projects |
21,726,252.28 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
273,852,245.85 |
| R&D expenses |
108,650,303.66 |
| Goodwill |
593,829,261.15 |
| Long-Term Deferred and Prepaid Expenses |
40,524,518.85 |
| Deferred Income Tax Assets |
121,547,419.86 |
| Other Non-Current Assets |
3,480,074.47 |
| Sub-Total of Non-Current Assets |
3,943,785,985.53 |
| Total Assets |
13,244,118,381.16 |
| Short-Term Loans |
2,508,678,482.50 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,005,561,966.80 |
| Accounts Payable |
1,225,452,566.20 |
| Accounts Received In Advance |
1,505,825.76 |
| Employee Compensation Payable |
13,312,691.37 |
| Taxes Payable |
65,071,496.97 |
| Interest Payable |
-- |
| Dividend Payable |
7,809,029.56 |
| Other payables |
230,940,522.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,477,508,622.22 |
| Other Current Liabilities |
135,560,467.80 |
| Sub-Total of Current Liabilities |
7,298,617,362.50 |
| Long-term Loans |
668,145,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
646,288,356.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
57,770,659.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,466,544,907.57 |
| Total Liabilities |
8,765,162,270.07 |
| Paid-In Capital(Or Share Stock) |
852,869,750.00 |
| Capital Surplus |
2,169,416,158.26 |
| Surplus Reserve |
104,050,836.58 |
| LESS:Treasury Stock |
242,065.62 |
| Undistributed Profits |
454,317,774.69 |
| Minority Stockholder's Interest |
898,914,704.97 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,580,041,406.12 |
| Owner's Equity（Stockholder's Equity） |
4,478,956,111.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,244,118,381.16 |
